Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Circulating nucleosomes levels improve FIT performance for detecting advanced adenomas in a symptomatic population

Thursday, February 29, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The presentation titled 'Circulating nucleosomes levels improve FIT performance for detecting advanced adenomas in a symptomatic population' was delivered at ASCO GI 2022 by Chang et al. The study suggests that measuring circulating nucleosome levels can enhance the effectiveness of the FIT test in identifying advanced adenomas among symptomatic individuals. This could lead to improved cancer detection strategies.
Price reaction · baseline $20.2 (2024-02-29T14:47:00.000Z) · hit during market hours · 3 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Improvement in FIT performance for detecting advanced adenomas.
  • Presentation highlights significant findings at ASCO GI 2022.
  • Potential for better cancer detection methods.

Full Press Release Details

Presentation title: “Circulating nucleosomes levels improve FIT performance for detecting advanced adenomas in a symptomatic population.”
Presented at ASCO GI 2022
Chang et al

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was the focus of the ASCO GI 2022 presentation?

The presentation focused on how circulating nucleosome levels improve FIT performance for detecting advanced adenomas.

Who presented the findings at ASCO GI 2022?

The findings were presented by Chang et al.

What is the significance of the study's findings?

The study suggests that measuring circulating nucleosome levels can enhance cancer detection methods.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare FIT test advanced adenomas ASCO GI 2022 cancer detection
Last updated: Feb 29, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk